Loading asset research
Biofrontera Inc. Common Stock
BFRINasdaq · USD · StocksQuote as of · Exchange session not verified$1.20
+4.35%
Today
BFRI
Loading 1D prices…
Market cap
$17.4M
Volume
280.5K
52w high
$1.6652w low
$0.555Company profile
Biofrontera Inc. Common Stock
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
WOBURN, MA, United States
Employees
84
Fiscal year end
1231
CIK
1858685
Session & valuation
Open$1.20
Previous close$1.20
Day high$1.23
Day low$1.16
30-day avg. volume749.5K
Outstanding shares14.9M
Diluted EPS-$1.04
Latest annual period
P/E (trailing)-1.15
P/E (forward)2.72
Price / book2.79
Beta0.84
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LPCNLipocine Inc. Common Stock | $17.4M | $2M | -487.18% | -$1.69 | -1.42% | Hold |
| NCELNewcelX Ltd. Ordinary Shares | $17.3M | $0.00 | — | $2.16 | +1.05% | Unrated |
| PTNPalatin Technologies Inc. Common Stock | $17.5M | $12.9M | -31.20% | -$1.63 | -4.28% | Unrated |
| CLRBCellectar Biosciences Inc. Common Stock | $17.9M | $0.00 | — | -$8.35 | -0.48% | Buy |
| ALLRAllarity Therapeutics Inc. Common Stock | $16.9M | $320K | -3509.69% | -$0.78 | +4.81% | Hold |